Introduction

Vaccines are like “training wheels” for the immune system. They contain small, harmless (attenuated or killed) fragments of microorganisms like viruses or bacteria or instructions (like mRNA) that teach the body to recognise and fight real infections. 

Unlike most medicines, which are given to treat people who are already sick, vaccines are given to healthy individuals, especially children, to prevent diseases before they strike. Since vaccines are so widely used in healthy populations, scientists hold them to even higher safety standards than other medical treatments.

Vaccines protect entire communities by stopping outbreaks, which is why they’re given to millions of healthy children worldwide. For example, measles vaccines alone have prevented over 23 million deaths since 2000, according to the World Health Organisation (WHO). In the UK, the measles, mumps, and rubella (MMR) vaccine has reduced measles cases by over 99% since its introduction, according to the UK Health Security Agency (UKHSA). 

As vaccines are used as a major preventative measure, they undergo rigorous testing in multiple clinical trial phases to ensure safety and effectiveness. Even after approval, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) monitors safety through systems like the Yellow Card Scheme, which tracks and investigates reported side effects.

Importance of vaccine safety in children

Vaccinations can provide protection against infections that are lethal to babies, kids, and grown-ups. Without immunisation, children are in danger of developing or dying from diseases like measles and whooping cough.

Vaccines provide protection, but like any drug or food item, there are dangers, such as allergic reactions. However, vaccinations have a phenomenal safety record, and researchers and scientists guarantee long-term wellbeing after investigations of vaccines and beneficiaries of vaccination.

History of vaccination

For a long time, people have searched for ways to shield themselves against infections. From tests and taking risks, vaccination has a long history. Vaccination has become the most powerful tool in preventing disease and has saved far more lives than any other medical advancement in history till date. According to the World Health Organisation (WHO), since 1974 alone, immunisation programmes have averted some 154 million deaths worldwide, adding billions of years of healthy life.¹

1400s to 1700s 

Early variolation practices

According to the World Health Organisation, from at least the 15th century, people in different parts of the world have sought to protect themselves by deliberately exposing healthy individuals to smallpox, a practice now known as variolation (from the French “variole” for smallpox). Some evidence even suggests variolation occurred as early as 200 BCE in Asia and Africa.

Introduction to europe

In 1721, Lady Mary Wortley Montagu witnessed variolation in Ottoman Turkey and had her own children inoculated there; she then championed the procedure in London when a smallpox epidemic struck in 1721.²

In 1774, farmer Benjamin Jesty in Dorset deliberately inoculated his wife and two sons with cowpox lymph taken from cattle, anticipating it would protect them against smallpox during a local outbreak.³

In May 1796, English Doctor Edward Jenner took material from a cowpox lesion on a milkmaid’s hand and inoculated eight‑year‑old James Phipps. Phipps recovered and later resisted smallpox infections. Jenner eventually coined the term “vaccination” from the Latin vacca (cow).⁴

The 1800s

Pasteur’s laboratory vaccines

In 1872, Louis Pasteur produced the first laboratory‑developed vaccine by attenuating the bacterium causing cholera in chickens. The vaccinated birds survived later exposure to the virulent strain.

In 1885, Pasteur extended this approach to rabies. He and Dr Jacques Joseph Grancher administered 13 progressively stronger post‑exposure injections to nine‑year‑old Joseph Meister, who survived and later worked at the Pasteur Institute. 

Diphtheria antitoxin development

In 1894, Dr Anna Wessels Williams isolated a highly toxigenic strain of diphtheria bacillus (“Park‑Williams No. 8”), which enabled the production of a reliable antitoxin and laid the groundwork for later diphtheria vaccination.

The 1900s

Spanish influenza and early flu vaccines

During the 1918–19 Spanish influenza pandemic, an estimated 20–50 million people died worldwide. The U.S. Army Medical School produced and distributed around two million doses of experimental influenza vaccine, but the results were inconclusive.

Yellow fever

In 1937, Max Theiler, Hugh Smith, and Eugen Haagen substituted the 17D yellow fever vaccine by attenuating the virus in chicken embryos. The vaccination was recognised in 1938, and more than 1 million individuals received the vaccine that year. Theiler was awarded the Nobel Prize later for this work.⁵

Pertussis vaccine

In 1939, bacteriologists Pearl Kendrick and Grace Eldering exhibited the efficacy of the pertussis (whooping cough) vaccination. The researchers show that immunisation reduces the rates at which children become sick from 15.1 per 100 children to 2.3 per 100 children.

Influenza vaccine approval

By 1945, primary flu immunisation (inactivated influenza A vaccine) was licensed for U.S. military use, and continued in 1946 by an endorsement for regular citizen use. The study was driven by specialists Thomas Francis Jr and Jonas Salk, who are also connected with the polio vaccine.⁶

Polio vaccines

Between 1952 and 1955, Jonas Salk developed the first effective inactivated polio vaccine and oversaw a mass trial involving 1.3 million children; in April 1955, it was declared safe and efficacious (80–90% protection).⁷

In 1960, Albert Sabin’s live‑attenuated oral polio vaccine was approved in the U.S.; its ease of administration led to mass “Sabin Sundays” and eventual global adoption.

Later 20th-century milestones

In 1967, the World Health Organisation launched its Intensified Smallpox Eradication Programme, supplying freeze‑dried vaccines worldwide. This campaign led to the eradication of smallpox by 1979, the first human disease ever eliminated through vaccination.

After discovering the “Australia antigen” in 1965, Baruch Blumberg’s team filed a vaccine patent in 1969. This recombinant vaccine subsequently prevented millions of hepatitis B infections and related liver cancers.

In 1971, Maurice Hilleman combined individual measles, mumps and rubella vaccines into the trivalent MMR shot, dramatically simplifying immunisation schedules and increasing uptake.⁸

A 14‑valent pneumococcal polysaccharide vaccine was licensed in 1977 and replaced by a 23‑valent version in 1983, reducing invasive pneumococcal disease by over 75% in target groups.

In 1985, the first Haemophilus influenzae type b (Hib) conjugate vaccine was licensed, after David H Smith established an organisation to create it.

In 1995, Anne Szarewski led trials linking human papillomavirus (HPV) to cervical pre‑cancer and pioneered HPV testing in screening. That work underpinned the development of HPV vaccines licensed in 2006.

The first rotavirus vaccine (RotaShield) was licensed in 1998 but withdrawn in 1999 over rare risks. Next‑generation oral vaccines (Rotarix, RotaTeq) became available in 2006, preventing up to 96% of severe rotavirus diarrhoea.

Common misconceptions about vaccine safety in children

Misconception: multiple vaccines at once are harmful

Concerns arise from expanding childhood vaccination schedules and combined shots. However, studies have consistently shown no increased risk of adverse events from recommended combined vaccines.^9,10

Misconception: some diseases are no longer a threat

Diseases like polio (poliomyelitis) remain endemic in two countries: Afghanistan and Pakistan, and any importation can seed outbreaks elsewhere until global eradication is achieved

Likewise, measles outbreaks continue worldwide and can occur when travellers bring the disease from endemic areas, highlighting the need for sustained vaccination. These data underscore that until a disease is eliminated everywhere, all countries remain at risk.

Misconception: more vaccinated people get sick during outbreaks

During outbreaks, both vaccinated and unvaccinated individuals can contract the disease. However, the vaccinated individuals have a much lower chance of developing the disease. 

Here’s a simple way to understand why seeing “more vaccinated people” among those who get sick doesn’t mean vaccines aren’t doing their job. This mix-up is called the base rate fallacy: we focus on who’s in the small group of sick people instead of remembering how many people were vaccinated in the first place. In logic, it’s when you ignore the “base rate” or overall size of each group and just look at a headline percentage. For example, imagine a town of 100 people where 80 are vaccinated and 20 are not. If 4 people catch a disease and it happens to be 2 vaccinated and 2 unvaccinated, you’d see “50% of cases are vaccinated”, even though vaccinated folks started out as four-fifths of the population. That doesn’t mean the shot failed; it just reflects the much larger vaccinated group.

In real U.S. measles data from 2001-2022, only about 11% of measles cases occurred in people who had been vaccinated, and those breakthrough cases were almost always milder than the cases in unvaccinated people. That means 89% of measles cases were in unvaccinated individuals which is a clear proof that vaccination cuts down your risk dramatically. ^11,12

A CDC report for January-April 2025, shows 96% of measles patients were unvaccinated or their status was unknown, so only 4% were vaccinated, again underscoring how rare breakthrough infections are when coverage is high. 

Misconception: hygiene and nutrition, not vaccines, lower disease rates

Improvements in water quality, sanitation, and nutrition drove large declines in all-cause and many infectious-disease mortality in the late 19th and early 20th centuries. However, for specific diseases, like measles, the dramatic drop in incidence and mortality coincided precisely with vaccine introduction. Between 2000 and 2022, global measles deaths fell from ~800,000 to ~107,500, largely attributable to vaccination programs that prevented an estimated 60 million childhood deaths.¹³

Misconception: natural immunity is superior

While infection can induce robust immunity, natural infection carries a high risk of serious complications. For example, in the case of measles, encephalitis in ~1 in 1,000 cases and death in ~1–2 in 1,000, plus evidence of long-term immune “amnesia” that increases susceptibility to other infections.¹⁴

Vaccination provides effective immunity with minimal risks, surpassing natural infection's protection, as seen with measles and other diseases. For example, two doses of measles vaccine confer >95% protection with an extremely low risk of serious adverse events (<1 in 1 million).

Misconception: vaccines cause autism

Thorough studies, including a nationwide Danish cohort of over 650,000 children, found no association between MMR vaccination and autism spectrum disorders.¹⁵ Even kids already at higher risk of autism (because an older sibling has it), don’t get autism more often if they get MMR.

Misconception: vaccine ingredients are toxic

The mercury in thimerosal (a preservative once used in some vaccines) leaves the body fast and is always at levels far below what could cause harm. When thimerosal was removed from most shots, autism rates didn’t change at all.¹⁶

Misconception: vaccine overload overwhelms the immune system

A baby meets thousands of germs and antigens every single day. Each vaccine adds only a few more, which the immune system handles easily. Getting several vaccines at once doesn’t “overwork” your child’s defences any more than their daily play does.¹⁷

Misconception: vaccines are not properly tested in children

Before any vaccine is approved for kids, it’s first tested in adults, then in thousands of children through carefully watched clinical trials. After approval, safety is tracked constantly through systems like VAERS and the Vaccine Safety Datalink to catch even very rare problems fast.⁹

Misconception: “shedding” from live vaccines can infect others

Live vaccines, like MMR, use weakened viruses that cannot spread disease to people around you. The only exception was the old oral polio vaccine which is no longer used, which could very rarely spread. Modern live shots are safe in this respect.

Vaccine safety testing and regulations

Vaccines go through three main stages before and after they reach you:¹⁸

• Preclinical testing in animals and lab dishes to check they’re safe and spur an immune response
• Clinical trials in people – first tiny safety checks, then larger studies for effectiveness, which are always done under strict ethical rules and with informed consent
• Approval and ongoing monitoring by regulators (like the UK’s MHRA or the U.S. FDA/CDC), plus safety-watch systems (for example, VAERS) that spot very rare side-effects once millions have been immunised

Preclinical testing phase

Before any human ever gets a dose, researchers must be confident it’s reasonably safe and able to train the immune system.

Animal studies

Scientists give the vaccine candidate to animals (often mice as a first step, sometimes non-human primates) to see if it causes any harm and whether antibodies or other immune cells develop. These tests also help pick the right dose to try in people and identify any unexpected toxicity early on.

Laboratory testing

In parallel, the vaccine is tested on human cells in the lab to check if it triggers the correct immune signals (for example, making certain proteins or activating immune cells). Researchers develop reliable tests (assays) to measure both the vaccine’s stability on the shelf and its potency before moving to human trials.

Clinical testing phase

Once preclinical data look good, an investigational new drug application is filed (e.g., to the U.S. FDA or UK MHRA), and human studies begin.

Phases of clinical trials

• Phase I – Very small (20–100 people), often healthy adults. Main goal: confirm safety and find the correct dose. Participants are closely watched for side effects
• Phase II – Usually a few hundred volunteers, sometimes including the target age groups (e.g., children or older adults). Researchers refine the dose and continue safety checks while gathering early efficacy data 
• Phase III – Thousands of participants across multiple sites. This is where scientists test how well the vaccine prevents disease, compare it against a placebo or existing vaccine, and look for rarer adverse events

Informed consent and ethical considerations

Every volunteer gets a plain-language information sheet explaining risks, benefits and their right to withdraw at any time. An independent ethics committee (or research ethics board) reviews the trial plan to protect participant welfare and ensure the study is worthwhile.

Vaccine approval process

Regulatory agencies (e.g., FDA, CDC, MHRA)

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) grants a marketing authorisation; in the U.S., the Food and Drug Administration (FDA) licenses vaccines, and the Centres for Disease Control and Prevention (CDC) issues immunisation recommendations. Regulators review all data - preclinical, clinical, manufacturing quality and labelling - before granting approval, ensuring benefits far outweigh any risks

Post-licensure monitoring systems (e.g., VAERS)

No trial can catch extremely rare side effects that might occur only once in hundreds of thousands of doses. That’s why passive systems like the Vaccine Adverse Event Reporting System (VAERS) in the U.S. collect any reports of health issues after vaccination. Active surveillance systems (e.g., the Vaccine Safety Datalink) and pharmaco-vigilance studies then investigate those reports to see if a real safety concern exists.⁹

How can vaccine safety concerns in children be addressed?

You have several reliable ways to get clear, accurate answers about vaccine safety for your child. You can talk directly with your healthcare provider, use official vaccine information sheets, explore public health campaigns, build trust through empathetic conversations, and keep up with ongoing research and safety monitoring. Each of these steps helps you make well-informed decisions and feel confident about vaccinating your child.

Talk to your healthcare providers

You can ask your doctor or nurse to explain vaccine safety in a way that makes sense to you, addressing any questions or worries you have. You can also request a friendly, open dialogue, your provider should listen respectfully and build trust as you discuss each vaccine’s risks and benefits. You can ask for the use of conversation aids, like flip charts or short videos, which many paediatricians have on hand to guide these chats and debunk common myths.

Look for official vaccine information statements

You can read Vaccine Information Statements (VISs), which explain a vaccine’s purpose, benefits, and possible side effects in plain language. You can also ask for these VISs every time your child is vaccinated, since they’re required by law in many countries and give you time to review and ask questions before the shot. 

Explore public health campaigns and educational resources

You can visit toolkits like RISE (Routine Immunisations on Schedule for Everyone) for easy-to-use guides on school and community vaccination support. You can also look up WHO’s immunisation campaign resources to see how vaccines are introduced and monitored worldwide, giving you global context for safety standards. You can follow updates from reputable organisations (e.g., NHS, CDC, WHO) on their websites or social media channels to catch new safety findings or schedule changes promptly.

Build trust and address hesitancy with empathy

You should seek out a healthcare team that acknowledges your concerns without judgment, offering personalised support rather than dismissing questions. If you want, you can attend community talks or Q&A sessions led by local health authorities or patient-advocacy groups, where you’ll hear answers delivered with empathy and respect. Parent forums or support groups moderated by professionals are also a good way to get evidence-based advice rather than unverified online rumours.

Stay informed on the research and development of safer vaccines

You can check the WHO’s vaccine safety pages to see how vaccines are continually monitored, even after approval, to catch any very rare side effects early. 

You can look up “Safety Information by Vaccine” on the CDC site for the latest studies and real-world safety data on each routine shot your child will receive.

You can also follow peer-reviewed journals (e.g., Journal of Experimental Medicine or Paediatrics) or summaries in medical news outlets to learn about advances in safer vaccine technologies and improved safety profiles.

Summary

You can get trustworthy answers about vaccine safety by talking openly with your healthcare provider, asking questions and hearing clear explanations, and by reading official information sheets (like the CDC’s Vaccine Information Statements) before each jab. You can also follow public health campaigns and check reliable sites (for example, the NHS or WHO) for up-to-date advice and myth-busting resources. It helps to build trust through honest, empathetic conversations, whether one-to-one with your doctor or at community Q&As, and to lean on parent forums moderated by professionals rather than unverified online chatter. Finally, know that vaccines undergo rigorous testing in labs and clinics, are approved by regulators, and stay under constant safety monitoring, so you can feel confident that research and real-world data keep your child’s protection both effective and safe.